We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Pipettes Offer Quality Assurance for Endotoxin-Sensitive Applications

By LabMedica International staff writers
Posted on 11 May 2010
A range of serological pipettes is now certified nonpyrogenic to 0.01 ELISA Units (EU)/mL, significantly lower than the market standard of 0.25 EU/mL. More...
The range has also been validated nonhemolytic.

When medical device and pharmaceutical manufacturers perform tests to ensure that their products are free from endotoxins, it is extremely important for them to have confidence in the equipment and materials that they use.

Similarly, when pipetting blood and blood products, it is important that the polymer used does not have a detrimental effect on the sample. Validated nonhemolytic, the serological pipettes protect samples and provide valuable assurance that they will not interfere with the results of hemolysis tests.

Certified nonpyrogenic to a very low level, Sterilin (Bargoed, UK) serological pipettes greatly reduce the risk of endotoxin interference in routine laboratory analyses (such as limulus amebocyte lysate--LAL testing) and, therefore, help to ensure the integrity of results.

Sterilin serological pipettes are manufactured from crystal grade polystyrene to ensure excellent clarity. With crisp black print, ascending and descending graduations, and negative graduations for extra capacity, volumes are extremely easy to read, and accurate to ± 1%.

The comprehensive range includes standard pipette sizes (1 mL, 2 mL, 5 mL, 10 mL, 25 mL, and 50 mL) in addition to "Shortie” pipettes (5 mL and 10 mL), which are ideal for use in laminar flow cabinets. The gamma-irradiated pipettes are individually wrapped in paper peel or plastic film to maintain quality during storage.

Related Links:

Sterilin




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.